Related by context. All words. (Click for frequent words.) 64 spontaneous preterm birth 64 venous blood clots 64 postoperative AF 64 endometriosis ovarian cysts 64 recurrent venous thromboembolism 63 contrast induced nephropathy 63 thromboembolic disease 63 venous thromboembolic events 63 PROCHIEVE R 62 atypical antipsychotic medications 62 cobiprostone 62 acute GVHD 62 cervical vulvar 62 spontaneous preterm delivery 62 colorectal adenoma 62 Prochieve R 8 62 Contrast Induced Nephropathy 61 genital herpes infections 61 treat dysmenorrhea 61 BENICAR HCT 61 acute onset CINV 61 cervical intraepithelial neoplasia 60 endometrial hyperplasia 60 venous thromboembolic disease 60 invasive aspergillosis 60 PROCHIEVE 8 60 GARDASIL ® 60 menstrual migraine 60 vaginally administered lidocaine 60 nonadherence 60 surgical adhesions 60 external genital lesions 60 recurrent pulmonary embolism 60 recurrent miscarriage 60 nonvertebral fractures 59 SRBD 59 chlamydial infection 59 DVT PE 59 CRBSI 59 oral PrEP 59 post surgical adhesions 59 oral RSD# 59 hormone therapy HT 58 CMV disease 58 invasive candidiasis 58 velafermin 58 thromboembolic diseases 58 adenoma recurrence 58 atherothrombotic events 58 Prochieve R 58 HER2 overexpression 58 preterm delivery 58 secondary amenorrhea 58 glucocorticoid induced osteoporosis 58 antioxidant supplementation 58 postpartum hemorrhage 58 direct thrombin inhibitors 58 atherogenic dyslipidemia 58 recurrent VTE 58 guideline concordant 58 atopic disease 58 containing granisetron 58 T1DM 58 Contrast Induced Nephropathy CIN 57 sustained virological response 57 LUTS 57 VivaGel TM 57 HPV-#/# 57 vertebral fracture 57 renal scarring 57 vulvovaginal atrophy 57 quadrivalent HPV vaccine 57 epithelial ovarian cancer 57 CIN2 + 57 grade cervical dysplasia 57 LHRH antagonists 57 CMV infection 57 thromboembolism 57 colorectal adenomas 57 TDF FTC 57 drospirenone containing 57 somatostatin analogs 57 LYSTEDA 57 prostate cancer CaP 57 serum folate concentrations 57 vaginal atrophy 57 virological failure 57 prostate cancer PCa 57 anovulatory infertility 57 CYP#D# inhibitor 57 norethindrone acetate 57 androgen deprivation 57 menopausal symptom 57 Calcium supplementation 57 postmenopausal hormone 57 STRIDE PD 57 thromboembolic events 57 vaginal estrogen 57 neonatal morbidity 57 premenstrual syndrome PMS 57 polyp recurrence 57 LNG IUS 57 advanced adenoma 57 thrombotic complications 56 conjugated equine estrogen 56 postmenopausal hormone replacement 56 antibody titer 56 alpha hydroxyprogesterone caproate 56 acute radiation enteritis 56 progesterone gel 56 COPD exacerbations 56 paroxetine Paxil 56 biologic DMARD 56 selenium supplementation 56 HGPIN 56 nocturnal hypoglycaemia 56 antiandrogen 56 lipid lowering agents 56 postoperative nausea 56 Hepatotoxicity 56 antibiotic prophylaxis 56 Xyfid TM 56 rectal microbicides 56 mammographic density 56 vasomotor symptoms 56 macrovascular events 56 PRO# [002] 56 Catheter Associated 56 postoperative pulmonary 56 reproductive tract infections 56 GnRH agonists 56 postoperative atrial fibrillation 56 FASLODEX 56 Androgen deprivation therapy 56 arterial thrombosis 56 rebleeding 56 symptomatic intracranial hemorrhage 56 divalproex sodium 56 Chlamydia infection 56 antithrombotics 56 maternal serum 56 singleton pregnancy 56 antithrombotic therapy 56 nonvertebral fracture 56 PROCHIEVE ® 8 56 pelvic malignancies 56 preterm birth 56 severe oral mucositis 56 clodronate 56 venous thrombosis 56 Helicobacter pylori eradication 56 folate supplementation 56 ROTARIX 55 lipid lowering therapies 55 Cardiotoxicity 55 antiemetics 55 systemic immunosuppressive drugs 55 5 HT3 antagonist 55 subclinical atherosclerosis 55 cervical carcinoma 55 TYGACIL 55 endometrial carcinoma 55 Pioglitazone 55 gestational hypertension 55 corticosteroid dose 55 nonvaccine 55 dose paroxetine mesylate 55 morphometric vertebral fractures 55 periprocedural MI 55 osteoporotic fractures 55 protease inhibitor PI 55 relapsed MM 55 arterial thromboembolic events 55 Renal Cell Carcinoma RCC 55 PONV 55 LibiGel ® 55 cervical cancer precancerous 55 ibandronate 55 vaginal lidocaine 55 tiagabine 55 bacterial vaginosis BV 55 trospium 55 virologic failure 55 abacavir Ziagen 55 CERVARIX 55 urolithiasis 55 RhD 55 Comorbidities 55 BRCA mutation carriers 55 antiandrogens 55 inhaled budesonide 55 CTAP# Capsules 55 See WARNINGS 55 delayed onset CINV 55 delayed CINV 55 oral anticoagulation 55 confidence interval #.#-#.# 55 Vascugel ® 55 ß blockers 55 dysmenorrhea 55 XIENCE V PROMUS Stent 55 tibolone 55 androgen suppression 55 thromboembolic complications 55 flutamide 55 beta carotene supplementation 55 GnRH agonist 55 levonorgestrel releasing 55 PRT# 55 antimicrobial prophylaxis 55 antidiabetic medication 55 urothelial carcinoma 55 antenatal depression 55 atherothrombotic 55 antiepileptics 55 caspofungin 55 severe rotavirus gastroenteritis 55 NNT = 55 serum phosphate 55 IM progesterone 55 PROCHIEVE 55 voiding dysfunction 55 cytomegalovirus infection 55 nucleoside naive patients 55 HMG CoA reductase inhibitors 55 abnormal mammograms 55 hereditary breast cancer 55 tipranavir 55 Decitabine 55 containing drospirenone 55 premenopausal breast cancer 55 definite stent thrombosis 55 NSAID induced 55 nonpregnant women 55 % CI #.#-#.# [003] 55 onset diabetes mellitus 55 norgestimate 55 Combination therapy 55 perinatal depression 54 Benign Prostatic Hyperplasia BPH 54 Recurrent Stroke 54 dose Iluvien 54 testosterone supplementation 54 QALE 54 parous women 54 cervicitis 54 APTIVUS 54 grade cervical intraepithelial 54 hematologic abnormalities 54 pharmacological treatments 54 dental caries tooth decay 54 acitretin 54 H2 blocker 54 induced hypoglycemia 54 glycated hemoglobin levels 54 fetal malformations 54 APTIVUS r 54 boosted protease inhibitor 54 dyslipidaemia 54 etiologic 54 chlamydial 54 vaginal hysterectomy 54 TEAEs 54 NMDA antagonists 54 A1c levels 54 Reynolds Risk Score 54 Tenofovir gel 54 genotypic resistance 54 oocytes retrieved 54 albumin excretion rate 54 lupus anticoagulant 54 leukotriene receptor antagonist 54 mycophenolate mofetil 54 upper gastrointestinal bleeding 54 elevated IOP 54 plus medroxyprogesterone acetate 54 aldosterone antagonists 54 Estrogens 54 HBsAg 54 CDI recurrence 54 antithrombotic agent 54 precancerous cervical lesions 54 transdermal testosterone 54 virological response 54 NIDDM 54 HbA 1c levels 54 Heavy menstrual bleeding 54 See CLINICAL PHARMACOLOGY 54 antithrombotic 54 Metastatic Prostate Cancer 54 thromboprophylaxis 54 hip BMD 54 perioperative morbidity 54 serum estradiol 54 fragility fractures 54 ischemic complications 54 medroxyprogesterone acetate 54 iPrEx study 54 Uterine Cancer 54 ORTHO EVRA 54 Prochieve 54 Elagolix 54 placental malaria 54 dysfunctional voiding 54 T2DM 54 antitrypsin 54 Degarelix 54 trimethoprim sulfamethoxazole 54 BENICAR 54 Cerebril TM 54 intracranial hemorrhage ICH 54 salmeterol fluticasone propionate 54 Colorectal cancer incidence 54 serum homocysteine 54 aromatase inhibitors AIs 54 Protease Inhibitors 54 PSA nadir 54 quadrivalent vaccine 54 Celecoxib 54 ocular toxicity 54 CVD mortality 54 multivariate Cox 54 suboptimal adherence 54 R0 resection 54 hyperphenylalaninemia HPA due 54 neurodevelopmental outcome 54 intravenous bisphosphonates 54 rotavirus gastroenteritis 54 multivitamin supplementation 54 VivaGel ™ 54 thrombophilia 54 hemolytic diseases 54 arterial calcification 54 folate intake 54 potentially modifiable 54 Pharmacologic 54 lucinactant 54 viral kinetics 54 venous thromboembolism VTE 54 ACE Inhibitors 54 hepatic fibrosis 54 multiple gestations 54 synthetic progestin 54 Nocturia 54 urine albumin 54 transdermal estrogen 54 ovulatory cycles 54 PPCM 54 EBRT 54 HbA1C 54 Lubiprostone 54 FSAD 54 IGRAs 54 deferiprone 54 NNRTI resistance 53 CINV 53 Treating Chronic 53 GnRH antagonist 53 thromboembolic 53 comorbid conditions 53 LB# [003] 53 SPRIX ® 53 atherothrombotic disease 53 FTC TDF 53 venous thromboembolism 53 teratogenic 53 APTIVUS ritonavir 53 antiplatelet medications 53 Kaplan Meier analysis 53 CANCIDAS 53 dysglycemia 53 G6PD deficiency 53 platelet reactivity 53 Respiratory Distress Syndrome 53 observational cohort 53 gastric stomach ulcers 53 oral mucositis OM 53 canakinumab 53 imiquimod cream 53 triglyceride concentrations 53 suicide ideation 53 subcutaneous immunoglobulin 53 overt hepatic encephalopathy HE 53 sotalol 53 hematological parameters 53 antihypertensive therapy 53 abnormal Pap smears 53 d4T stavudine Zerit 53 renal toxicity 53 NovaSure endometrial ablation 53 COPD exacerbation 53 tumor recurrence 53 recurrent genital herpes 53 Natazia 53 antidiabetic drugs 53 recurrent UTI 53 abnormal lipid 53 depot medroxyprogesterone acetate 53 postexposure prophylaxis 53 incontinence episodes 53 nucleotide analog 53 hemorrhagic complications 53 orofacial clefts 53 containing abacavir 53 pegylated IFN 53 antidiabetic medications 53 doxorubicin HCl 53 #mg dose [002] 53 EFFEXOR XR 53 ALISTA 53 Decompensated Heart Failure 53 Posaconazole 53 AZOR 53 perinatal outcomes 53 subclinical hypothyroidism 53 leukotriene pathway 53 conjugated estrogen 53 luteal 53 adjuvant radiotherapy 53 pCR 53 esophagogastric 53 paricalcitol 53 goserelin 53 tipranavir ritonavir 53 obstetric complications 53 Female Sexual Dysfunction 53 fluoxetine paroxetine 53 LV dysfunction 53 invasive ductal 53 maternal morbidity 53 tumor necrosis 53 palivizumab 53 orally inhaled migraine 53 hormone therapy estrogen 53 variceal bleeding 53 nucleoside analogues 53 suppressive therapy 53 coronary stenosis 53 colorectal cancer CRC 53 Tindamax R 53 amoxicillin clavulanate 53 vaginal infections 53 genital ulcer disease 53 postexposure 53 prospective observational studies 53 Thromboembolism 53 Etravirine 53 micafungin 53 MetS 53 atypical ductal hyperplasia 53 abacavir lamivudine 53 GI toxicity 53 preterm neonates 53 REYATAZ ritonavir 53 SHBG levels 53 CHD mortality 53 HeFH 53 ovarian carcinoma 53 endometrial cancers 53 systemic corticosteroid 53 exploratory endpoints 53 secondary hyperparathyroidism 53 macrovascular 53 posaconazole 53 protease inhibitors PIs 53 plasma pharmacokinetics 53 abdominal adiposity 53 recurrent UTIs 53 Breast Density 53 nevirapine Viramune 53 serum testosterone 53 AST ALT 53 hypovitaminosis D 53 Influenza vaccination 53 ablative therapy 53 IOP lowering 53 anovulation 53 multivariable adjusted 53 MICARDIS ® 53 tumor histology 53 HNSCC 53 advanced neoplasia 53 lipid abnormalities 53 liposomal amphotericin B 53 keloid scarring 53 hypercalciuria 53 CLINICAL PHARMACOLOGY 53 chronic HBV 53 Prehypertension 53 rFSH 53 Palonosetron 53 autologous SCT 53 5 Fluorouracil 53 plasma folate 53 thiopurine 53 p = #.# [003] 53 neoplasia 53 % uracil topical 53 carotid IMT 53 lexidronam injection 53 labetalol 53 ductal cancer 53 Paraplatin ® 53 Prosaptide 53 mTOR inhibition 53 oral contraceptive pills 53 symptomatic fibroids 53 pulmonary fungal infections 53 TT genotype 53 lipid parameters 53 transdermal estradiol 53 Acute Ischemic Stroke 53 latent tuberculosis infection 53 Oral Mucositis 53 intact parathyroid hormone 53 ximelagatran 53 Noxafil 53 ductal carcinomas 53 Drospirenone 53 retrograde ejaculation 53 tamoxifen Nolvadex ® 53 breast abscesses 53 Vagifem 53 antipsychotic induced 53 hepatocellular carcinoma liver 53 vaginal microbicides 53 Vitamin D supplementation 53 topical NSAIDs 53 BEXXAR Therapeutic Regimen 53 symptomatic benign prostatic 53 TOVIAZ 52 distal colon cancer 52 Toxicities 52 valent pneumococcal conjugate vaccine 52 confidence interval CI 52 CIN3 52 perinatal transmission 52 iron supplementation 52 Adjuvant chemotherapy 52 Carvedilol 52 Renal dysfunction 52 postmenopausal breast cancer 52 % CI #.#-#.# [004] 52 conjugate vaccines 52 symptomatic VTE 52 homocysteine concentrations 52 bronchopulmonary dysplasia 52 Oral contraceptives 52 ORTHO EVRA R 52 ARIXTRA R 52 cervical vaginal 52 idraparinux 52 ATACAND 52 Desmopressin 52 zidovudine lamivudine 52 post menopausal osteoporosis 52 voriconazole 52 Mitomycin C 52 quadrivalent human papillomavirus 52 nonpharmacologic 52 ularitide 52 Sexually Transmitted Infections STI 52 serum lipid levels 52 VLBW 52 Combination antiretroviral therapy 52 ALT elevation 52 doxorubicin docetaxel 52 interstitial brachytherapy 52 mycophenolate mofetil MMF 52 platelet inhibitor 52 cat dander allergy 52 virologic failures 52 cardiotoxicity 52 Interferon beta 1b 52 OAB symptoms 52 serum urate 52 eculizumab therapy 52 PREZISTA r 52 inactivated poliovirus vaccine 52 pramlintide metreleptin combination 52 Celebrex celecoxib 52 INVANZ 52 ORTHO TRI CYCLEN LO 52 neoplasia PIN 52 cervical lesions 52 Kivexa 52 zidovudine AZT 52 ARB telmisartan 52 rFVIIa 52 Immunotherapeutic 52 glatiramer acetate 52 Effexor venlafaxine 52 locoregional recurrence 52 p = .# [002] 52 Invasive Fungal Infections 52 salmeterol fluticasone 52 long acting bronchodilator 52 DHEA supplementation 52 metachronous 52 Kaplan Meier estimates 52 % CI #.#-#.# [008] 52 HBV infection 52 NMIBC 52 serum uric acid 52 certolizumab 52 cotrimoxazole 52 pharmacologic treatments 52 symptomatic hyponatremia 52 endometrial thickness 52 FRAGMIN 52 anticoagulation therapy 52 serum IgE 52 PHPT 52 chronic HCV infection 52 clotrimazole 52 varenicline Chantix 52 Unstable angina 52 colorectal neoplasia 52 herpes zoster vaccine 52 Chlamydia trachomatis infection 52 Hepatocellular Carcinoma HCC 52 vulvovaginal candidiasis 52 fetal chromosomal 52 plasma homocysteine 52 systemic toxicity 52 cranial irradiation 52 intrapartum 52 topical microbicide 52 CYT# potent vascular disrupting 52 breast cancer recurrence 52 acromegalic patients 52 dorzolamide 52 knee osteoarthritis OA 52 precancerous cervical 52 myocardial infarctions MIs 52 thyrotropin 52 Bezielle 52 Ischemic 52 Gestational 52 Sustiva efavirenz 52 elevated CRP 52 oxcarbazepine 52 assessing T DM1 52 binary restenosis 52 sociodemographic characteristics 52 Myocardial Perfusion Imaging 52 INFERGEN 52 operable breast cancer 52 NRTI backbone 52 micronutrient supplements 52 perioperative mortality 52 pelvic lymphadenectomy 52 ICD implantation 52 transdermal gel 52 osteoporotic fracture 52 cardiovascular morbidity 52 hypercholesterolaemia 52 zoledronic acid Zometa 52 anal cancers 52 histologic subtype 52 angiographic restenosis 52 dentin hypersensitivity 52 leiomyomas 52 hypogonadal men 52 antiplatelet agents 52 hydroxyvitamin D levels 52 ARESTIN ® 52 antiestrogen 52 ovulation induction 52 DDP# 52 nulliparous women 52 psychiatric comorbidities 52 ACAPODENE 52 oral antiplatelet 52 antihypertensive medications 52 external beam radiotherapy 52 Colorectal cancer screening 52 antithrombotic therapies 52 endogenous estrogen 52 nonfasting triglyceride levels 52 Injectable Suspension 52 Human Papillomavirus 52 tipranavir r 52 desogestrel 52 postoperative morbidity 52 P. vivax malaria 52 recombinant follicle stimulating 52 VTEs 52 piroxicam 52 valacyclovir 52 noninferior 52 torsemide ER 52 prostate carcinogenesis 52 HBeAg negative 52 pharmacologic intervention 52 Erythropoietic therapies may 52 gonococcal infections 52 deep venous thromboses 52 diabetes mellitus DM 52 ATL/TV# 52 pneumococcal carriage 52 surgical prophylaxis 52 nocturnal enuresis 52 DHA supplementation 52 Hormone Refractory Prostate Cancer 52 analgesic medications 52 clomiphene citrate 52 Symptom Relief 52 oral antiplatelet therapy 52 NATRECOR R 52 ICD implants 52 KETEK 52 BPH LUTS 52 letrozole Femara 52 breast carcinoma 52 vivo potency 52 cardioprotective effects 52 infusional 52 corticosteroid therapy 52 cardiovascular disease CVD 52 TOPAMAX ® 52 radical prostatectomy RP 52 Xyfid 52 β blockers 52 thrombotic events 52 Didanosine 52 androgen deficiency 52 Hydroxyurea 52 urinary symptoms 52 perfusion abnormalities 52 GP IIb IIIa inhibitors 52 Retreatment 52 corifollitropin alfa 52 beta estradiol 52 gemifloxacin 52 refractory gout 52 antiretroviral prophylaxis 52 virologic response 52 organ transplant rejection 52 hypercholesterolemia 52 mRCC 51 IUGR 51 serum PSA 51 serum concentrations 51 % Confidence Interval 51 Faslodex 51 microbicide gels 51 Darapladib 51 donepezil Aricept 51 KRN# 51 LHRH agonist 51 ALA PDT 51 estradiol valerate 51 ALT flares 51 dosing frequency 51 MMRV vaccine 51 Adenomas 51 glycosylated hemoglobin levels 51 thiazide diuretics 51 neurodevelopmental impairment 51 dose atorvastatin 51 bilateral oophorectomy 51 abnormal pap tests 51 overt nephropathy 51 Peginterferon 51 paclitaxel Taxol 51 postoperative complication 51 noncardiovascular mortality 51 testicular tumors 51 thalidomide Thalomid 51 APOE e4 51 Hodgkin lymphoma HL 51 dyspareunia 51 HPV subtypes 51 hsCRP 51 periprocedural 51 seropositivity 51 nonhormonal 51 strontium ranelate 51 AUDs 51 intrauterine contraception 51 elevated ALT 51 seroconversion 51 oral prednisolone 51 PCa 51 urothelial bladder cancer 51 empiric therapy 51 Femara letrozole 51 Hb A1C 51 FIRMAGON 51 adenoidectomy 51 DermaVir Patch 51 pentoxifylline 51 transdermal contraceptive 51 sustained virologic response 51 pre menopausal 51 unnecessary cesareans 51 HCV Genotype 51 C. trachomatis 51 carotid artery stenting CAS 51 Moxifloxacin 51 urinary incontinence 51 nonfatal stroke 51 gonadotropins 51 NATRECOR ® 51 SGPT 51 Ozarelix 51 carotid plaques 51 Allogeneic 51 bevacizumab Avastin ® 51 psychiatric comorbidity 51 terbutaline 51 vaginal cancers 51 disorder FSAD 51 HCV antibody 51 postoperative infections 51 rhGH 51 Gonal f 51 trials RCTs 51 folic acid supplementation 51 medroxyprogesterone 51 serum IGF 51 pharmacodynamic properties 51 RCTs 51 TransVax TM 51 fragility fracture 51 Candesartan 51 systolic hypertension 51 DETROL LA 51 Silodosin 51 proton pump inhibitor PPI 51 Lp PLA 2 51 rotavirus diarrhea 51 delaying childbirth 51 varicocele 51 Kinoid 51 precursor lesions 51 cervical dysplasia 51 antiplatelet therapy 51 advanced adenomas 51 ovarian cervical 51 multivariable analysis 51 postoperative mortality 51 AA Amyloidosis 51 tolterodine ER 51 salivary flow 51 pneumococcal vaccination 51 randomized controlled trials RCTs 51 evaluating tivozanib 51 CIMZIA ™ 51 Prophylactic 51 hemodilution 51 undergoing radical prostatectomy 51 cirrhotic patients 51 LAMICTAL 51 cerebral vasospasm 51 risk HPV genotypes 51 Meta analyzes 51 bone metastasis 51 cardiac dysfunction 51 abnormal uterine bleeding 51 folic acid intake 51 Pazopanib 51 forodesine 51 vaginal microbicide 51 glycosylated hemoglobin HbA1c 51 KIF6 carriers 51 transferrin saturation 51 G CSFs 51 coadministration 51 neovascularisation 51 anticonvulsant medications 51 opioid misuse 51 Abciximab 51 pertussis Tdap vaccine 51 deCODE BreastCancer TM 51 atazanavir Reyataz 51 reinfarction 51 indinavir 51 HBeAg positive patients 51 Venous Thromboembolism VTE 51 antiplatelet therapies 51 Candida infection 51 antimuscarinic 51 prostate cancer CRPC 51 PPSV# 51 HBeAg 51 dual endothelin receptor antagonist 51 empiric 51 lipohypertrophy 51 Acute Coronary Syndromes ACS 51 agomelatine 51 proliferative retinopathy 51 micronutrient supplementation 51 oesophageal adenocarcinoma 51 lipid lowering therapy 51 Doxil ® 51 hemoglobin A1c HbA1c 51 neurodevelopmental outcomes 51 platelet activation 51 prolactin levels 51 VTE prophylaxis 51 INTELENCE 51 calcium supplementation 51 prophylactic therapy 51 ZOSTAVAX 51 HbA1C levels 51 Bacterial Vaginosis 51 colorectal liver metastases 51 HIV seroconversion 51 sodium thiosulfate STS 51 Atopic Dermatitis 51 inflammatory biomarkers 51 anal HPV 51 microvascular complications 51 oral NSAIDs 51 Double Blind Randomized 51 Havrix 51 RISPERDAL ® 51 renoprotective 51 Sudden Cardiac Death 51 HAART initiation 51 localized prostate cancer 51 dapsone 51 REYATAZ ® 51 atherosclerotic renal artery stenosis 51 Melphalan 51 chronic periodontitis 51 tHcy 51 Zemplar Capsules 51 leukocyte count 51 parasitemia 51 Percutaneous Tibial Nerve Stimulation 51 recurrent ovarian cancer 51 recurrent atrial fibrillation 51 ENDOMETRIN 51 anticholinergic agents 51 invasive breast cancer 51 efavirenz EFV 51 Aptivus ® 51 Chemotherapy induced 51 liver metastasis 51 FOLOTYN ® 51 edifoligide E2F Decoy 51 nonfatal MI 51 bioavailable testosterone 51 recurrent DVT 51 candidemia 51 Androgenetic Alopecia 51 anal incontinence 51 XL# SAR# 51 epithelial tumors 51 pain palliation 51 bacterial vaginosis 51 Pre Exposure Prophylaxis 51 perioperative complications 51 radioiodine therapy 51 initiating antiretroviral therapy 51 AMOR IPAT 51 atherosclerotic vascular disease 51 Human papillomavirus HPV 51 Progestin 51 Subgroup analyzes 51 cervical ripening 51 dyslipidemias 51 urinary tract symptoms 51 chlamydial infections 51 artemisinin derivative 51 estrogen hormone therapy 51 erythropoietic 51 oral contraception 51 urinary calcium 51 finasteride Proscar 51 proguanil 51 severe hyperbilirubinemia 51 CCR5 inhibitor 51 Follicular Lymphoma 51 myopathy rhabdomyolysis 51 docetaxel Taxotere ® 51 overactive bladder OAB 51 Genital Herpes 51 hyperphosphatemia 51 interferon ribavirin 51 estrogen progestin therapy 51 INVEGA ® 51 diabetic gastroparesis 51 HbF 51 Capesaris 51 adjuvant radiation 51 adenomatous polyps 51 acetazolamide 51 recombinant FSH 51 atherosclerotic progression 51 Anthracycline 51 APTIVUS R 51 proctitis 51 Adhibit 51 TNF alpha inhibitor 51 orlistat Xenical